Deep Learning in Healthcare Market Outlook

The global deep learning in healthcare market size was valued at approximately $2.8 billion in 2023 and is projected to reach around $13.7 billion by 2032, growing at a robust compound annual growth rate (CAGR) of 19.4% during the forecast period. The rapid integration of artificial intelligence (AI) and machine learning technologies in healthcare systems, alongside advancements in computational power and data availability, are significant growth drivers for the market.

One of the primary growth factors for the deep learning in healthcare market is the increasing demand for efficient and accurate diagnostic tools. Deep learning algorithms have demonstrated superior performance in interpreting medical images, detecting anomalies, and predicting outcomes compared to traditional methods. This has led to widespread adoption in medical imaging, significantly enhancing diagnostic precision and reducing the burden on healthcare professionals. The ever-increasing volume of healthcare data, coupled with the need for quick and accurate decision-making, further propels the market forward. By leveraging large datasets, deep learning can achieve a level of precision and speed unattainable by human capabilities alone.

Another significant driver is the growing emphasis on personalized medicine. Deep learning enables the analysis of complex biological data, aiding in the development of personalized treatment plans tailored to individual patient profiles. This shift towards precision medicine is transforming patient care, allowing for more effective treatment protocols and better patient outcomes. The pharmaceutical industry, in particular, is investing heavily in deep learning technologies to expedite drug discovery and development processes, thereby reducing time-to-market and costs associated with bringing new drugs to consumers.

The adoption of electronic health records (EHRs) and the integration of AI in healthcare administration are also crucial growth factors. Deep learning algorithms can process vast amounts of patient data stored in EHRs to identify patterns and predict disease outbreaks, optimize resource allocation, and enhance patient management. The demand for streamlined operations and improved patient care is driving healthcare providers to incorporate these advanced technologies. Furthermore, the ongoing advancements in computational power and the availability of high-quality healthcare datasets are crucial enablers for the application of deep learning technologies in various healthcare domains.

Computer Vision in Healthcare is revolutionizing the way medical professionals approach diagnostics and treatment planning. By leveraging advanced image processing algorithms, computer vision can analyze medical images with remarkable accuracy, identifying patterns and anomalies that might be missed by the human eye. This technology is not only enhancing the precision of medical imaging but also enabling the development of automated systems that assist radiologists in interpreting complex datasets. The integration of computer vision in healthcare is streamlining workflows, reducing diagnostic errors, and ultimately improving patient outcomes. As the technology continues to evolve, its applications are expanding beyond imaging to include areas such as surgery, pathology, and patient monitoring, offering a comprehensive toolset for modern healthcare delivery.

On the regional front, North America holds the largest share of the deep learning in healthcare market, driven by substantial investments in AI technology, well-established healthcare infrastructure, and supportive government initiatives. The region's focus on technological innovation and its robust research ecosystem are key factors contributing to market growth. Moreover, the presence of leading AI and healthcare companies in North America accelerates the adoption of deep learning technologies. Europe and Asia Pacific are also witnessing significant growth, with the latter expected to exhibit the highest CAGR during the forecast period due to increasing healthcare digitization and rising investments in AI-driven healthcare solutions.

Component Analysis

The deep learning in healthcare market is segmented by component into software, hardware, and services. The software segment is anticipated to dominate the market owing to continuous advancements in AI algorithms and the development of sophisticated software solutions tailored for healthcar

This dataset is made available under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). See LICENSE.pdf for details.

Dataset description

Parquet file, with:

• 35694 rows
• 154 columns

The file is indexed on [participant]_[month], such that 34_12 means month 12 from participant 34. All participant IDs have been replaced with randomly generated integers and the conversion table deleted.

Column names and explanations are included as a separate tab-delimited file. Detailed descriptions of feature engineering are available from the linked publications.

File contains aggregated, derived feature matrix describing person-generated health data (PGHD) captured as part of the DiSCover Project (https://clinicaltrials.gov/ct2/show/NCT03421223). This matrix focuses on individual changes in depression status over time, as measured by PHQ-9.

The DiSCover Project is a 1-year long longitudinal study consisting of 10,036 individuals in the United States, who wore consumer-grade wearable devices throughout the study and completed monthly surveys about their mental health and/or lifestyle changes, between January 2018 and January 2020.

The data subset used in this work comprises the following:

• Wearable PGHD: step and sleep data from the participants’ consumer-grade wearable devices (Fitbit) worn throughout the study
• Screener survey: prior to the study, participants self-reported socio-demographic information, as well as comorbidities
• Lifestyle and medication changes (LMC) survey: every month, participants were requested to complete a brief survey reporting changes in their lifestyle and medication over the past month
• Patient Health Questionnaire (PHQ-9) score: every 3 months, participants were requested to complete the PHQ-9, a 9-item questionnaire that has proven to be reliable and valid to measure depression severity

From these input sources we define a range of input features, both static (defined once, remain constant for all samples from a given participant throughout the study, e.g. demographic features) and dynamic (varying with time for a given participant, e.g. behavioral features derived from consumer-grade wearables).

The dataset contains a total of 35,694 rows for each month of data collection from the participants. We can generate 3-month long, non-overlapping, independent samples to capture changes in depression status over time with PGHD. We use the notation ‘SM0’ (sample month 0), ‘SM1’, ‘SM2’ and ‘SM3’ to refer to relative time points within each sample. Each 3-month sample consists of: PHQ-9 survey responses at SM0 and SM3, one set of screener survey responses, LMC survey responses at SM3 (as well as SM1, SM2, if available), and wearable PGHD for SM3 (and SM1, SM2, if available). The wearable PGHD includes data collected from 8 to 14 days prior to the PHQ-9 label generation date at SM3. Doing this generates a total of 10,866 samples from 4,036 unique participants.

Get premium quality off-the-shelf EHR dataset to develop better performing machine learning models. Speak to our experts for Electronic Health Records data needs.

Oral diseases affect nearly 3.5 billion people, with the majority residing in low- and middle-income countries. Due to limited healthcare resources, many individuals are unable to access proper oral healthcare services. Image-based machine learning technology is one of the most promising approaches to improving oral healthcare services and reducing patient costs. Openly accessible datasets play a crucial role in facilitating the development of machine learning techniques. However, existing dental datasets have limitations such as a scarcity of Cone Beam Computed Tomography (CBCT) data, lack of matched multi-modal data, and insufficient complexity and diversity of the data. This project addresses these challenges by providing a dataset that includes 329 CBCT images from 169 patients, multi-modal data with matching modalities, and images representing various oral health conditions.

1) Data Introduction • The Healthcare Dataset is a synthetic dataset designed to mimic real-world healthcare data for data science, machine learning, and data analysis purposes. It includes patient information, medical conditions, admission details, and healthcare services provided. This dataset is ideal for developing and testing healthcare predictive models, practicing data manipulation techniques, and creating data visualizations.

2) Data Utilization (1) Healthcare data has characteristics that: • It includes detailed patient information such as age, gender, blood type, medical condition, and admission details. This information can be used to analyze healthcare trends, patient demographics, and the effectiveness of medical treatments. (2) Healthcare data can be used to: • Predictive Modeling: Helps in developing models to predict patient outcomes, treatment success rates, and disease progression. • Healthcare Analytics: Assists in analyzing patient data to identify patterns, improve patient care, and optimize resource allocation. • Educational Purposes: Supports learning and teaching data science concepts in a healthcare context, providing realistic data for experimentation and practice.

The AI training dataset market is experiencing robust growth, driven by the increasing adoption of artificial intelligence across diverse sectors. The market's expansion is fueled by the need for high-quality, labeled data to train sophisticated AI models capable of handling complex tasks. Applications span various industries, including IT, automotive, healthcare, BFSI (Banking, Financial Services, and Insurance), and retail & e-commerce. The demand for diverse data types—text, image/video, and audio—further fuels market expansion. While precise market sizing is unavailable, considering the rapid growth of AI and the significant investment in data annotation services, a reasonable estimate places the 2025 market value at approximately $15 billion, with a compound annual growth rate (CAGR) of 25% projected through 2033. This growth reflects a rising awareness of the pivotal role high-quality datasets play in achieving accurate and reliable AI outcomes. Key restraining factors include the high cost of data acquisition and annotation, along with concerns around data privacy and security. However, these challenges are being addressed through advancements in automation and the emergence of innovative data synthesis techniques. The competitive landscape is characterized by a mix of established technology giants like Google, Amazon, and Microsoft, alongside specialized data annotation companies like Appen and Lionbridge. The market is expected to see continued consolidation as larger players acquire smaller firms to expand their data offerings and strengthen their market position. Regional variations exist, with North America and Europe currently dominating the market share, although regions like Asia-Pacific are projected to experience significant growth due to increasing AI adoption and investments.

The AI Training Dataset in Healthcare market is poised for substantial growth, projected to reach an estimated market size of approximately $1,500 million by 2025, with a Compound Annual Growth Rate (CAGR) of around 25% anticipated through 2033. This robust expansion is fueled by the escalating demand for accurate and comprehensive datasets essential for training sophisticated AI models in healthcare applications. Key drivers include the increasing adoption of Electronic Health Records (EHRs), the growing sophistication of medical imaging analysis, and the proliferation of wearable devices that generate vast amounts of patient data. Furthermore, the rapid advancements in telemedicine, amplified by recent global health events, necessitate highly refined datasets to power remote diagnostics, personalized treatment plans, and predictive analytics. The market's dynamism is also evident in its segmentation; text-based data, encompassing clinical notes and research papers, currently holds a significant share due to its foundational role in natural language processing for healthcare. However, image/video data, crucial for medical imaging interpretation and surgical simulations, is expected to witness accelerated growth. The competitive landscape is characterized by the presence of major technology giants and specialized AI data providers, including Google, Microsoft, Amazon Web Services, and Scale AI, alongside niche players like Alegion and Appen Limited. These companies are actively investing in data annotation, curation, and synthetic data generation to address the unique challenges of healthcare data, such as privacy concerns (HIPAA compliance) and the need for domain expertise. Emerging trends like federated learning and explainable AI are further shaping the market, requiring new approaches to data training and validation. Restraints, such as stringent regulatory frameworks and the high cost of acquiring and annotating high-quality, diverse healthcare data, are being addressed through technological innovations and strategic partnerships. The Asia Pacific region, particularly China and India, is emerging as a significant growth hub due to the expanding digital health infrastructure and a growing focus on AI adoption in healthcare. This comprehensive report delves into the burgeoning AI Training Dataset market within the healthcare sector. Analyzing the period from 2019 to 2033, with a focus on the base year 2025, this study provides an in-depth understanding of market dynamics, key players, and future projections. The global market for AI training datasets in healthcare is projected to reach millions by 2025 and experience significant growth throughout the forecast period.

📌 Introduction

This dataset is a synthetic yet realistic simulation of newborn baby health monitoring.
It is designed for healthcare analytics, machine learning, and app development, especially for early detection of newborn health risks.

The dataset mimics daily health records of newborn babies, including vital signs, growth parameters, feeding patterns, and risk classification labels.

🎯 Motivation

Newborn health is one of the most sensitive areas of healthcare.
Monitoring newborns can help detect jaundice, infections, dehydration, and respiratory issues early.

Since real newborn data is private and hard to access, this dataset provides a safe and realistic alternative for researchers, students, and developers to build and test:
- 📊 Exploratory Data Analysis (EDA)
- 🤖 Machine Learning classification models
- 📱 Healthcare monitoring apps (Streamlit, Flask, Django, etc.)
- 🏥 Predictive healthcare systems

📂 Dataset Overview

• Total Babies: 100
• Monitoring Period: 30 days per baby
• Total Records: 3,000
• File Format: CSV
• Synthetic Data: Generated using Python (pandas, numpy, faker) with medically-informed rules

📑 Column Description

🔹 Demographics

• baby_id → Unique identifier for each baby (e.g., B001).
• name → Randomly generated baby first name (for realism).
• gender → Male / Female.
• gestational_age_weeks → Gestational age at birth (normal: 37–42 weeks).
• birth_weight_kg → Birth weight (normal range: 2.5–4.5 kg).
• birth_length_cm → Length at birth (avg: 48–52 cm).
• birth_head_circumference_cm → Head circumference at birth (avg: 33–35 cm).

🔹 Daily Monitoring

• date → Monitoring date.
• age_days → Age of baby in days since birth.
• weight_kg → Daily updated weight (growth trend ~25–30g/day).
• length_cm → Daily updated body length (slow increase).
• head_circumference_cm → Daily updated head circumference.
• temperature_c → Body temperature in °C (normal: 36.5–37.5°C).
• heart_rate_bpm → Heart rate (normal: 120–160 bpm).
• respiratory_rate_bpm → Breathing rate (normal: 30–60 breaths/min).
• oxygen_saturation → SpO₂ level (normal >95%).

🔹 Feeding & Hydration

• feeding_type → Breastfeeding / Formula / Mixed.
• feeding_frequency_per_day → Number of feeds per day (normal: 8–12).
• urine_output_count → Wet diapers/day (normal: 6–8+).
• stool_count → Bowel movements per day (0–5 is common).

🔹 Medical Screening

• jaundice_level_mg_dl → Bilirubin level (normal <5, mild 5–12, severe >15).
• apgar_score → 0–10 score at birth (only day 1).
• immunizations_done → Yes/No (BCG, HepB, OPV on Day 1 & 30).
• reflexes_normal → Newborn reflex check (Yes/No).

🔹 Risk Classification

• risk_level → Automatically assigned health status:
  • ✅ Healthy → All vitals normal.
  • ⚠️ At Risk → Mild abnormalities (e.g., mild jaundice, slight fever, SpO₂ 92–95%).
  • 🚨 Critical → Severe abnormalities (e.g., jaundice >15, SpO₂ <92, HR >180, temp >39°C).

📊 How Data Was Generated

The dataset was generated in Python using:
- numpy and pandas for data simulation.
- faker for generating baby names and dates.
- Medically realistic rules for vitals, growth, jaundice progression, and risk classification.

💡 Potential Applications

• Machine Learning: Train classification models to predict newborn health risks.
• Streamlit/Dash Apps: Build real-time newborn monitoring dashboards.
• Healthcare Research: Study growth and vital sign patterns.
• Education: Practice EDA, visualization, and predictive modeling on health datasets.

📬 Author & Contact

Created by [Arif Miah]
I am passionate about AI, Healthcare Analytics, and App Development.
You can connect with me:

• 📺 YouTube → [https://www.youtube.com/@intelliaiworld]
• 💼 LinkedIn → [www.linkedin.com/in/arif-miah-8751bb217]
• 💻 GitHub → [https://github.com/Arif-miad]

⚠️ Disclaimer

This is a synthetic dataset created for educational and research purposes only.
It should NOT be used for actual medical diagnosis or treatment decisions.

These synthetic patient datasets were created for machine learning (ML) study of lung cancer risk prediction and simulation study of learning health systems.

1. In subfolder "unconverted": Five populations of 30K patients were generated by the Synthea patient generator. About 1100 lung cancer patients and 3000 control patients (without lung cancer) were selected and their electronic health records (EHR) were processed to data table files ready for machine learning using common algorithms like XGBoost.

2. In root directory: The five 30K-patient datasets were combined sequentially to form 5 different size datasets, from 30K to 150K patients. The new datasets were resampled to keep all lung cancer patients plus about 3x control patients. The ML-ready table files also had the continuous numeric values converted to categorical values.

Because Synthea patients are closely resemble real patients, the Synthea patient data can be used to develop and test ML algorithms and pipelines, and train researchers. Unlike real patient data, these Synthea datasets can be shared with collaborators anywhere without privacy concerns.

The first LHS simulation study titled "Simulation of a machine learning enabled learning health system for risk prediction using synthetic patient data" has been published in Nature Scientific Reports (see https://www.nature.com/articles/s41598-022-23011-4).

Diabetes, a chronic metabolic condition characterised by persistently high blood sugar levels, necessitates early detection to mitigate its risks. Inadequate dietary choices can contribute to various health complications, emphasising the importance of personalised nutrition interventions. However, real-time selection of diets tailored to individual nutritional needs is challenging because of the intricate nature of foods and the abundance of dietary sources. Because diabetes is a chronic condition, patients with this illness must choose a healthy diet. Patients with diabetes frequently need to visit their doctor and rely on expensive medications to manage their condition. It is challenging to purchase medication for chronic illnesses on a regular basis in underdeveloped nations. Motivated by this concept, we suggest a hybrid model that, rather than depending solely on medication to evade a visit to the doctor, can first anticipate diabetes and then suggest a diet and exercise regimen. This research proposes an optimized approach by harnessing machine learning classifiers, including Random Forest, Support Vector Machine, and XGBoost, to develop a robust framework for accurate diabetes prediction. The study addresses the difficulties in predicting diabetes precisely from limited labeled data and outliers in diabetes datasets. Furthermore, a thorough food and exercise recommender system is unveiled, offering individualized and health-conscious nutrition recommendations based on user preferences and medical information. Leveraging efficient learning and inference techniques, the study achieves a meager error rate of less than 30% using an extensive dataset comprising over 100 million user-rated foods. This research underscores the significance of integrating machine learning classifiers with personalized nutritional recommendations to enhance diabetes prediction and management. The proposed framework has substantial potential to facilitate early detection, provide tailored dietary guidance, and alleviate the economic burden associated with diabetes-related healthcare expenses.

Unlock valuable biomedical knowledge with our comprehensive PubMed Dataset, designed for researchers, analysts, and healthcare professionals to track medical advancements, explore drug discoveries, and analyze scientific literature.

Dataset Features

Scientific Articles & Abstracts: Access structured data from PubMed, including article titles, abstracts, authors, publication dates, and journal sources. Medical Research & Clinical Studies: Retrieve data on clinical trials, drug research, disease studies, and healthcare innovations. Keywords & MeSH Terms: Extract key medical subject headings (MeSH) and keywords to categorize and analyze research topics. Publication & Citation Data: Track citation counts, journal impact factors, and author affiliations for academic and industry research.

Customizable Subsets for Specific Needs Our PubMed Dataset is fully customizable, allowing you to filter data based on publication date, research category, keywords, or specific journals. Whether you need broad coverage for medical research or focused data for pharmaceutical analysis, we tailor the dataset to your needs.

Popular Use Cases

Pharmaceutical Research & Drug Development: Analyze clinical trial data, drug efficacy studies, and emerging treatments. Medical & Healthcare Intelligence: Track disease outbreaks, healthcare trends, and advancements in medical technology. AI & Machine Learning Applications: Use structured biomedical data to train AI models for predictive analytics, medical diagnosis, and literature summarization. Academic & Scientific Research: Access a vast collection of peer-reviewed studies for literature reviews, meta-analyses, and academic publishing. Regulatory & Compliance Monitoring: Stay updated on medical regulations, FDA approvals, and healthcare policy changes.

Whether you're conducting medical research, analyzing healthcare trends, or developing AI-driven solutions, our PubMed Dataset provides the structured data you need. Get started today and customize your dataset to fit your research objectives.

• Numerous language-centric research on healthcare is conducted day by day. To address shortcomings of Arabic natural language generation models, we introduce a large Arabic Healthcare Dataset (AHD) of textual data. For this motivation, we named our dataset ‘AHD’.

• The largest Arabic Healthcare Dataset (AHD) as we know was collected from altibbi website.

• The AHD consists of more than 808k Question and Answer into 90 variety categories. The AHD contains one file, and the file description will be discussed here. One file is the actual data which is in Arabic language.

  • AHD.xlsx file contains dataset in excel format, which includes the question, answer, and category in Arabic.

  • AHD_english.xlsx file contains dataset in excel format, which includes the question, answer, and category translated to English.

• Distribution of Question and Answer per category.xlsex shows the distribution of the data set by category.

Synthetic Health Data Market Outlook

According to our latest research, the global synthetic health data market size reached USD 312.4 million in 2024. The market is demonstrating robust momentum, growing at a CAGR of 31.2% from 2025 to 2033. By 2033, the synthetic health data market is forecasted to achieve a value of USD 3.14 billion. This remarkable growth is primarily driven by the increasing demand for privacy-compliant, high-quality datasets to accelerate innovation across healthcare research, clinical trials, and digital health solutions.

One of the most significant growth drivers for the synthetic health data market is the intensifying focus on data privacy and regulatory compliance. Healthcare organizations are under mounting pressure to adhere to stringent regulations such as HIPAA in the United States and GDPR in Europe. These frameworks restrict the sharing and utilization of real patient data, creating a critical need for synthetic health data that mimics real-world datasets without compromising patient privacy. The ability of synthetic data to facilitate research, AI training, and analytics without the risk of identifying individuals is a key factor fueling its widespread adoption among healthcare providers, pharmaceutical companies, and research organizations globally.

Technological advancements in artificial intelligence and machine learning are further propelling the synthetic health data market forward. The sophistication of generative models, such as GANs and variational autoencoders, has enabled the creation of highly realistic and diverse synthetic datasets. These advancements not only enhance the quality and utility of synthetic health data but also expand its applicability across a wide range of use cases, from medical imaging to genomics. The integration of synthetic data into clinical workflows and drug development pipelines is accelerating time-to-market for new therapies and improving the reliability of predictive analytics, thereby contributing to better patient outcomes and operational efficiencies.

Another critical factor supporting market expansion is the growing emphasis on interoperability and data sharing across the healthcare ecosystem. Synthetic health data enables seamless collaboration between diverse stakeholders, including healthcare providers, insurers, and technology vendors, by eliminating privacy barriers. This collaborative environment fosters innovation in areas such as population health management, personalized medicine, and remote patient monitoring. Additionally, the adoption of synthetic data is helping to address the challenges of data scarcity and bias, particularly in underrepresented populations, ensuring that AI models and healthcare solutions are more equitable and effective.

From a regional perspective, North America leads the synthetic health data market, accounting for the largest revenue share in 2024. This dominance is attributed to the region’s advanced healthcare infrastructure, high adoption of digital health technologies, and strong presence of key market players. Europe is following closely, driven by rigorous data protection regulations and a rapidly growing research ecosystem. The Asia Pacific region is emerging as a high-growth market, fueled by increasing investments in healthcare technology, expanding clinical research activities, and rising awareness about the benefits of synthetic health data. Latin America and the Middle East & Africa are also witnessing steady growth, supported by government initiatives to modernize healthcare systems and improve data-driven decision-making.

Component Analysis

The synthetic health data market is segmented by component into software and services, each playing a pivotal role in shaping the industry landscape. The software segment encompasses platforms and tools designed to generate, manage, and validate synthetic health datasets. These solutions leverage advanced machine learning algorithms and generative models to produce high-fidelity synthetic data that closely mirrors

About this Dataset

This dataset will help you apply your existing knowledge to great use. This dataset has 132 parameters on which 42 different types of diseases can be predicted. This dataset consists of 2 CSV files. One of them is for training and the other is for testing your model. Each CSV file has 133 columns. 132 of these columns are symptoms that a person experiences and the last column is the prognosis. These symptoms are mapped to 42 diseases you can classify these sets of symptoms. You are required to train your model on training data and test it on testing data.

Category

Machine Learning

Keywords

medicine,disease,Healthcare,ML,Machine Learning

Row Count

4962

Price

$109.00

BackgroundResearch related to Artificial Intelligence (AI) in healthcare applications is evolving. It is essential to incorporate collaborative learning from published research to comprehend the challenges and accessibility of opportunities when integrating AI in healthcare systems. To investigate the role of AI, a qualitative and quantitative year in review study was conducted, encompassing the evaluation of literature published in 2024 to gain insight into the recent advancements of the field.MethodsTo find research articles about integrating new AI technologies into healthcare systems, a PubMed search using the terms “2024”, “artificial intelligence”, and “large language models” was conducted. The search was restricted to human subject research and used a deep-learning-based approach to assess the reliability of publications as of December 31, 2024 on January 1, 2025. In addition, for each publication, each mature article was manually annotated for the AI model type (e.g., LLM, DL, ML), healthcare specialty, and the data type used (image, text, tabular, or audio).Additionally,qualitative and quantitative analyses were performed to illuminate statistics and trends of combined published articles.ResultsOur PubMed search yielded 28,180 total articles; 1,693 were initially labeled mature, after which 1,551 articles were analyzed after exclusions. Similar to the prior years, we excluded systematic reviews in the final analysis and were excluded in this year's dataset.The most prevalent specialties within our PubMed search originated from imaging (407), head and neck (127), and General (122). Analysis of AI model types showed that the Large Language Model (LLM) was the most popular utilized in 479 publications, followed by AI General (448), and DL (372). Qualitative data was obtained on the data types, and it was revealed that the image data was predominant and used in 57.0% of the mature sources, followed by text (33.1%), followed by tabular (7.59%). The utilization of Large Language Models (LLMs) is the highest in publications associated with education at 18.6%, followed by General at 13.6%. These results indicate that LLMs are frequently applied in educational contexts and administrative tasks amongst the healthcare specialties for research.ConclusionHealthcare specialties, including imaging, head and neck, and general medicine, have taken over the realm of AI in healthcare. Other specialties that distinctive types of AI and LLMs could likely drive in the future include education, pathology, as well as surgery. It is essential to use a collaborative approach to investigate the multimodal models of AI in healthcare applications to provide a thorough encapsulation of AI in healthcare.Data Files DescriptionOne data file is provided, which illustrates the annotations of the mature sources used in our review. The first file is named Annotated_OnlyMature_Unique_2024_YIR_All_Publications - Annotated_OnlyMature_Unique_2024_YIR_All_Publications and includes ‘Title’, ‘DOI’, ‘Abstract’, ‘Author Address’, ‘Specialty’, ‘Model’, and 'Data Type’. The ‘Specialty’, ‘Model’, and ‘Data Type’ were predominantly analyzed by the BrainXAI research team to produce our meta-analysis of the mature sources of AI. This year we have excluded systematic reviews from the dataset compared to the 2023 year in review dataset, but can be provided on request.

The dataset is structured in a tabular format and consists of disease-symptom relationships. it is organized as follows: the first column represents diseases, the remaining columns represent symptoms. Each cell contains a binary value (1 or 0), where 1 indicates that the symptom is associated with the disease and 0 indicates no association. There are 85 Unique Diseases, 172 Symptoms along with 758 Disease-Symptoms Relations. To use the dataset, please cite the following: R. Zannat, A. Al Shafi and A. Muntakim, "Bridging the Gap in Bangla Healthcare: Machine Learning Based Disease Prediction Using a Symptoms-Disease Dataset," 2025 International Conference on Electrical, Computer and Communication Engineering (ECCE), Chittagong, Bangladesh, 2025, pp. 1-6, doi: 10.1109/ECCE64574.2025.11012950. URL: https://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=11012950&isnumber=11012919

This dataset is designed to facilitate machine learning research focused on predicting newborn birth weight outcomes based on maternal characteristics. It reflects a realistic set of features that influence neonatal health and risk mitigation.

The data simulates 200 maternal records, each consisting of clinical, demographic, and lifestyle factors. The target variable, birth_weight_category, classifies birth weight into two categories: Low and Normal, based on a computed risk score derived from domain-relevant medical conditions.

The dataset is well-suited for classification tasks in maternal healthcare analytics, risk assessment modeling, and early intervention research.

🔑 Key Features Feature Name Description age Age of the mother (in years) pre_pregnancy_bmi Body Mass Index before pregnancy gestational_age_weeks Gestational age at birth (in weeks) blood_pressure_systolic Systolic blood pressure (mmHg) blood_pressure_diastolic Diastolic blood pressure (mmHg) hemoglobin_level Hemoglobin concentration (g/dL) number_of_prenatal_visits Total number of prenatal healthcare visits has_diabetes Whether the mother has diabetes (1 = Yes, 0 = No) has_hypertension Whether the mother has hypertension (1 = Yes, 0 = No) smoking_status Smoking status during pregnancy ('Yes' or 'No') alcohol_consumption Alcohol use during pregnancy ('Yes' or 'No') education_level Mother's highest education level ('None', 'Primary', 'Secondary', 'Higher') household_income Estimated monthly household income (in local currency) iron_supplementation Whether the mother took iron supplements (1 = Yes, 0 = No) birth_weight_category Target variable: 'Low' or 'Normal' birth weight classification

Blood datasets typically encompass a broad array of information related to hematology, blood chemistry, and related health indicators. These datasets often include data points such as blood cell counts, hemoglobin levels, hematocrit, platelet counts, white blood cell differentials, and various blood chemistry parameters such as glucose, cholesterol, and electrolyte levels.

These datasets are invaluable for medical research, clinical diagnostics, and public health initiatives. Researchers and healthcare professionals utilize blood datasets to study hematological disorders, monitor disease progression, assess treatment efficacy, and identify risk factors for various health conditions.

Machine learning techniques are often applied to blood datasets to develop predictive models for diagnosing diseases, predicting patient outcomes, and identifying biomarkers associated with specific health conditions. These models can assist clinicians in making more accurate diagnoses, designing personalized treatment plans, and improving patient care.

Additionally, blood datasets play a crucial role in epidemiological studies and population health research. By analyzing large-scale blood datasets, researchers can identify trends in blood parameters across different demographic groups, assess the prevalence of blood disorders, and evaluate the impact of lifestyle factors and environmental exposures on hematological health.

Overall, blood datasets serve as valuable resources for advancing our understanding of hematology, improving healthcare practices, and promoting better health outcomes for individuals and populations.

Training, validation, and testing datasets used in Machine Learning-Based Grading of Engine Health for High-Performance Vehicles

Finding a good data source is the first step toward creating a database. Cardiovascular illnesses (CVDs) are the major cause of death worldwide. CVDs include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other heart and blood vessel problems. According to the World Health Organization, 17.9 million people die each year. Heart attacks and strokes account for more than four out of every five CVD deaths, with one-third of these deaths occurring before the age of 70. A comprehensive database for factors that contribute to a heart attack has been constructed. The main purpose here is to collect characteristics of Heart Attack or factors that contribute to it. The size of the dataset is 1319 samples, which have nine fields, where eight fields are for input fields and one field for an output field. Age, gender, heart rate (impulse), systolic BP (pressurehight), diastolic BP (pressurelow), blood sugar(glucose), CK-MB (kcm), and Test-Troponin (troponin) are representing the input fields, while the output field pertains to the presence of heart attack (class), which is divided into two categories (negative and positive); negative refers to the absence of a heart attack, while positive refers to the presence of a heart attack.